The Japan brain health supplements market is estimated at USD 705.2 million in 2025, rising to USD 819.4 million in 2026 and reaching about USD 3,316.4 million by 2035, at a 16.8% CAGR from 2026 to 2035. Growth is driven by the fast-aging population, rising attention to mental health, and preventive healthcare. Demand for memory, attention, mood and sleep supplements, plus innovation in natural molecules, herbal extracts and functional ingredients, supports expansion.
Market Highlights
Natural molecules and herbal extracts accounted for over 38.6% of 2025 revenue.
Tablets and capsules are projected to grow at a 17.2% CAGR from 2026 to 2035.
Memory enhancement held just under 33.5% of 2025 demand.
Pharmacies and drugstores supplied about 20% of 2025 revenue.
Significant Growth Factors
Product innovation and ingredient recognition, including a November 2024 award for Kyowa Hakko Bio's Cognizin citicoline.
Brain health showcases at Health Ingredients Japan 2025 highlighting preventive cognitive care.
Brand competition from Alpha-GPC, ginseng-based and established health companies.
Regulatory and Industry Developments
Food with Function Claims (FFC) allows companies to describe cognitive benefits, prompting firms such as FANCL and Meiji Holdings to align products with approved ingredients like DHA, ginkgo biloba and phosphatidylserine. The report also cites automated manufacturing, consolidation including Kirin's 2024 acquisition of FANCL, and local sourcing of key nutrients.
Category Insights
Natural molecules such as DHA/EPA, phosphatidylserine, amino acids and antioxidants are favored for clinical support. Herbal extracts like ginkgo biloba, bacopa and ashwagandha are growing fast. Tablets and capsules dominate for convenience and dosing accuracy; powders are growing quickly. Memory enhancement leads, supported by an aging population, while attention and focus is a high-growth segment. Pharmacies and drugstores dominate distribution due to consumer trust, while online retail is growing rapidly.
Report Scope
Feature
Details
Market Size 2026
USD 819.4 million
Projected Size 2035
USD 3,316.4 million
Market Size 2025
USD 705.2 million
CAGR
16.8% (2026-2035)
Base Year
2025
Major Developments
March 2025: FANCL launched a DHA and plant-based cognitive supplement.
July 2024: Otsuka released a next-generation DHA-based brain health product.
May 2025: Meiji Holdings set up a cognitive R&D center in Tokyo.
March 2025: Eisai presented an age-related memory soft gel.
Meet the team
This report was prepared by our expert analysts with deep industry knowledge and hands-on research experience.
VJ
Veena Jagtap
Author · Healthcare Research Manager
A results-driven Healthcare Research Manager at Custom Market Insights, specializing in healthcare market intelligence, industry analysis, competitive benchmarking, and strategic market assessments. Experienced in managing end-to-end healthcare research projects, analyzing industry trends, evaluating competitive landscapes, and identifying emerging market opportunities across pharmaceuticals, biotechnology, medical devices, healthcare services, and life sciences.
Skilled in leading research initiatives, developing customized research methodologies, and transforming complex market data into actionable business insights. With a strong analytical mindset, strategic perspective, and commitment to research excellence, I focus on delivering accurate, data-driven intelligence that empowers clients to make informed business decisions, strengthen market positioning, and achieve sustainable growth in the evolving global healthcare industry.
Table of Contents
Explore the chapters covered in the full report.
Chapter 1. Report Introduction
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 USP & Key Offerings
1.2 Key Benefits For Stakeholders
1.3 Target Audience
1.4 Report Scope
Chapter 2. Market Overview
2.1 Market Definition & Scope
2.2 Key Market Takeaways
2.3 Market Snapshot
Chapter 3. Market Dynamics (DRO)
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Market Trends
Chapter 4. Japan Brain Health Supplements Market - By product type
4.1 natural molecules and herbal extracts
4.2 vitamins and minerals
Chapter 5. Japan Brain Health Supplements Market - By form
5.1 tablets and capsules
5.2 powders
5.3 soft gels
Chapter 6. Japan Brain Health Supplements Market - By application
6.1 memory enhancement
6.2 attention and focus
6.3 mood and stress management
6.4 anti-aging and longevity
Chapter 7. Japan Brain Health Supplements Market - By distribution channel
7.1 pharmacies and drugstores
7.2 online retail
7.3 supermarkets and hypermarkets
Chapter 8. Japan Brain Health Supplements Market - Regional Analysis
8.1 North America
8.2 Europe
8.3 Asia Pacific
8.4 Middle East & Africa
8.5 Latin America
Chapter 9. Competitive Landscape
9.1 Market Share Analysis
9.2 Company Benchmarking
9.3 Strategic Developments
Chapter 10. Company Profiles
10.1 FANCL Corporation
10.2 Otsuka Pharmaceutical Co. Ltd.
10.3 Ajinomoto Co. Inc.
10.4 Meiji Holdings Co. Ltd.
10.5 Kyowa Hakko Bio Co. Ltd.
10.6 Daiichi Sankyo Company Limited
10.7 Eisai Co. Ltd.
10.8 Takeda Pharmaceutical Company Limited
10.9 Suntory Holdings Limited
10.10 Yakult Honsha Co. Ltd.
10.11 Nippon Shinyaku Co. Ltd.
10.12 Kobayashi Pharmaceutical Co. Ltd.
Chapter 11. Research Methodology
11.1 Research Approach
11.2 Data Collection & Sources
11.3 Market Estimation & Forecasting
11.4 Data Validation & Triangulation
Chapter 12. Standard Report Commercials & Add-OnsChapter 13. List Of FiguresChapter 14. List Of Tables
Company Listing
FANCL Corporation
Otsuka Pharmaceutical Co. Ltd.
Ajinomoto Co. Inc.
Meiji Holdings Co. Ltd.
Kyowa Hakko Bio Co. Ltd.
Daiichi Sankyo Company Limited
Eisai Co. Ltd.
Takeda Pharmaceutical Company Limited
Suntory Holdings Limited
Yakult Honsha Co. Ltd.
Nippon Shinyaku Co. Ltd.
Kobayashi Pharmaceutical Co. Ltd.
Market Segments
Market Segmentation
By product type: natural molecules and herbal extracts, vitamins and minerals, others. By form: tablets and capsules, powders, soft gels. By application: memory enhancement, attention and focus, mood and stress management, anti-aging and longevity. By distribution channel: pharmacies and drugstores, online retail, supermarkets and hypermarkets.
Frequently asked questions
What drives market growth?
The aging population, growing attention to mental health, preventive healthcare, demand for natural and science-backed ingredients, and ongoing product innovation.
Which region leads?
The Kanto region, especially the Tokyo metropolitan area, with Kansai also showing strong growth potential.
What will the market size be by 2035?
About USD 3,316.4 million by the end of the forecast period, at a 16.8% CAGR.
What role do regulations play?
The Ministry of Health, Labour and Welfare oversees quality, safety and labeling, and the FOSHU and FFC frameworks add credibility and consumer trust.